Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AGN-231868
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Allergan Aesthetics
Deal Size : $5.0 million
Deal Type : Collaboration
Eurobio Scientific Receives a $430,000 Milestone Payment From Allergan
Details : During the clinical development of AGN-231868, Eurobio Scientific remains eligible to other milestone payments linked to successful transitions to further clinical stages.
Product Name : AGN-231868
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 10, 2021
Lead Product(s) : AGN-231868
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Allergan Aesthetics
Deal Size : $5.0 million
Deal Type : Collaboration